We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

DIASOURCE

Develops, manufactures, and markets clinical diagnostic products that focus on endocrinology and infectious diseases read more Featured Products: More products

Download Mobile App





DiaSource Presents New Trio of ELISA Instruments

By LabMedica International staff writers
Posted on 11 Nov 2024

DiaSource ImmunoAssays S. More...

A. (Walloon Brabant, Belgium) is showcasing its full product range, from ELISA and RIA tests to antibodies and cutting-edge instruments at MEDICA 2024.

DiaSource is also announcing the addition of a new rapid test (POCT) and its respective reader to its portfolio. These products complete the company’s panel with additional technologies and interesting parameters in the fields of women’s health, tumor markers, drugs of abuse, infectious diseases, and cardiac markers. DiaSource is also launching a series of new antibodies in the fields of Alzheimer's disease, cardiac markers, diabetes, and fertility. These antibodies have proven to be reliable raw materials in the manufacturing of immunoassays such as CLIA, ELISA, FIA, and POCT.

At this year’s MEDICA, DiaSource is highlighting the new version of its ELISA reader, washer, and shaker. DiaSource’s new range of instruments for manual ELISA tests include the ELISA Plate Reader (DIA2000), ELISA Plate Washer (DIA3000), and ELISA Plate Shaker (DIA4000). These instruments now have a modern, sophisticated look, with an improved user interface designed to simplify the laboratory's operations and streamline data management. The ELISA Plate Reader (DIA2000), now IVDR compliant, is designed according to the principle of enzyme-linked immunoassay technology. Developed with a vertical 8-channel optical path, it can be used for single and dual wavelength measurements. The advantage is to provide absorbance, qualitative, and quantitative test results.

The ELISA Plate Washer (DIA3000) is a laboratory device specially used for cleaning microplates and performing the wash step in an ELISA procedure. It is generally used in conjunction with the ELISA Plate Reader. The user-friendly operating system allows customization of various parameters such as plate type, number of washes, wash solution quantity, plate washing method, suction point, soaking and stirring time. Its outstanding performance results in residual volumes of less than 1µl, using a 2-point aspiration process to help better achieve these precise results. The ELISA Plate Shaker (DIA4000) is mainly used for shaking and heating ELISA microplates during the incubation step of an ELISA procedure. In terms of heating, the advantage of this shaker is that it can heat both the top and bottom of the cover, significantly improving the temperature uniformity of the microplate. It also has a good sealing system to ensure that the temperature remains stable throughout the incubation period.

Related Links:
DiaSource ImmunoAssays S.A.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Toxoplasma Gondii Test
Toxo IgG ELISA
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.